A component-level RoHS report can look reassuring while answering the wrong question. Directive 2011/65/EU applies maximum concentration values to each homogeneous material, not to the mass-weighted average of a finished component. Mixing molding compound, leadframe alloy, plating, bond wire, termination materials, and solder into one result can therefore hide a small material layer that exceeds its applicable limit.
This does not mean that every incoming lot needs ten full chemical tests. It means that the evidence plan must start with material identity. Supplier documentation, change control, risk-based screening, and confirmatory analysis can all contribute, but each piece of evidence needs a defined part number, material scope, method, date, and regulatory basis.
Start with the legal measurement unit
RoHS defines a homogeneous material as one material of uniform composition throughout, or a combination that cannot be separated into different materials by mechanical actions such as unscrewing, cutting, crushing, grinding, or abrasion. European Commission guidance uses examples such as a plastic housing, the copper conductor in a cable, and the solder portion of a solder joint. The concentration limit is applied to those materials individually.
A component package is not automatically homogeneous. A molded device may contain a polymer compound, leadframe alloy, surface finish, internal wire, die attach, ink, ceramic body, barrier layer, or termination metal. If these regions are distinct materials or can be mechanically separated, a single whole-part average does not replace material-level assessment.
Keep the ten restricted substances attached to their limits
Annex II lists ten restricted substances. The maximum concentration value is 0.1% by weight in a homogeneous material for lead, mercury, hexavalent chromium, PBB, PBDE, DEHP, BBP, DBP, and DIBP. Cadmium has a 0.01% limit. In equivalent units, 0.1% is 1,000 mg/kg and 0.01% is 100 mg/kg.
| Material-level limit | Restricted substances | Analytical caution |
|---|---|---|
| 0.1% (1,000 mg/kg) | Pb, Hg, Cr(VI), PBB, PBDE | Elemental screening does not necessarily identify oxidation state or compound |
| 0.01% (100 mg/kg) | Cd | Sampling and quantification capability still need to match the material |
| 0.1% (1,000 mg/kg) | DEHP, BBP, DBP, DIBP | Phthalates require methods suitable for the target compounds and polymer matrix |
Those values are not a substitute for checking scope and exemptions. Annex III and Annex IV exemptions are application-specific and can have category and expiry conditions. A current decision therefore needs the applicable consolidated text, the equipment category, the material use, the market date, and any claimed exemption—not a timeless statement that a substance is always permitted or always prohibited.
How a whole-part average can create a false pass
Consider an illustrative 100 mg component containing a 0.2 mg coating. If that coating contained a restricted substance at 0.2%, or 2,000 mg/kg, the restricted-substance mass would be 0.0004 mg. Dividing by the whole component would produce an apparent average of only 4 mg/kg, far below 1,000 mg/kg. The coating itself, however, remains above a 0.1% homogeneous-material limit.
This numerical example demonstrates dilution only; it is not a real test result or an exemption decision. It also shows why a report needs a sample description. “Electronic component” is not enough. The reader should know whether the result represents molding resin, a metal alloy, a plated surface, a solder region, or a deliberately combined screening sample.
XRF is a screening tool, not a ten-substance verdict
IEC 62321-3-1:2026 covers X-ray fluorescence (XRF) screening for elements including lead, mercury, cadmium, total chromium, and total bromine in uniform materials. XRF can efficiently classify samples as low concern, clearly high concern, or requiring more work. Its usefulness depends on geometry, thickness, matrix effects, surface layers, calibration, detection capability, and the screening thresholds chosen for the decision.
An elemental result does not always identify the regulated form. Total chromium is not a direct measurement of Cr(VI), and total bromine is not a direct measurement of PBB or PBDE. Phthalates are organic compounds and are not established by an ordinary elemental XRF screen. IEC 62321 includes separate methods: Part 6 addresses PBB/PBDE in polymers, Parts 7-1 and 7-2 address Cr(VI) in different material contexts, and Parts 8 or 12 address phthalates. The laboratory method must match both the material and the analyte.
Technical documentation and laboratory testing have different jobs
The European Commission published EN IEC 63000:2018 as a harmonized standard for technical documentation supporting RoHS assessment. The evidence package can include supplier declarations, material declarations, specifications, certificates of conformity, purchasing controls, risk assessment, change notifications, screening, and targeted test reports. A laboratory report is valuable evidence, but it does not by itself control future changes or identify every upstream material.
Conversely, a one-line supplier statement may be too weak if it lacks a part number, revision, production scope, date, exemption basis, or change-control commitment. Evidence strength should follow risk. A stable, well-controlled material with traceable documentation may justify less testing; a new source, recycled polymer, plating change, past failure, ambiguous exemption, or near-threshold screen calls for stronger material-specific confirmation.
Build a material map before ordering a test
Use drawings, bills of materials, full material declarations, cross-sections, process knowledge, and supplier data to list every plausible homogeneous material. For a passive or molded electronic component, the list may include the functional ceramic or polymer body, internal electrodes, barrier layers, terminal finish, leadframe, molding compound, bond wire, adhesive, ink, and solder. Record which materials can be separated and which thin layers require a surface-specific strategy.
Very thin plating can be difficult to isolate or collect in sufficient mass. That preparation constraint must be documented rather than treated as proof that the layer is irrelevant. Ask the laboratory to identify the measurement location, sample preparation, represented material, reporting limit, and uncertainty. Do not transfer one report across factories, finishes, or material systems unless its declared scope supports that use.
A seven-step evidence workflow
- Lock the manufacturer, part number, drawing or specification revision, site, lot, and change status.
- Confirm RoHS scope and review the current restricted-substance list, applicable exemptions, category, and dates.
- Create a homogeneous-material map with location, composition, upstream supplier, and separability for every layer.
- Collect part-specific declarations, material disclosures, certificates, reports, and change-control records; verify identity and validity dates.
- Rank risk by material and analyte, then decide where XRF screening is appropriate and where a compound-specific method is needed.
- Confirm near-threshold, non-uniform, conflicting, or chemically ambiguous results; never close the gap with a whole-part average.
- Retain photographs, disassembly records, method, detection and reporting limits, units, uncertainty, decision rule, and exemption rationale.
What to check in a supplier or laboratory report
| Review line | Question the evidence must answer | Weak shortcut |
|---|---|---|
| Sample identity | Does the part, lot, site, photograph, and date match? | “Electronic components” or a family name only |
| Material identity | Is the result for resin, alloy, plating, solder, or another defined region? | Treating the finished part as one material |
| Method capability | Does the analyte, matrix, detection limit, and preparation fit? | Calling total Cr or total Br a compound-specific result |
| Decision rule | Are units, threshold, uncertainty, and inconclusive range explicit? | A PASS label without concentration or rule |
| Exemption and revision | Is the exact use, clause, expiry, and document revision stated? | “Complies with latest RoHS” without scope |
Common failure modes in incoming inspection
The first failure is using a whole component to obtain a convenient low average. The second is using an XRF result as though it identified Cr(VI), PBB, PBDE, or phthalates directly. The third is reporting “not detected” as zero without checking the reporting limit. The fourth is accepting a supplier declaration that cannot be traced to the purchased revision or production source.
A sound decision also leaves room for “inconclusive.” A result close to a screening threshold may be dominated by measurement uncertainty, geometry, coating thickness, or matrix correction. An inconclusive classification is not a failure of the process; it is the trigger for better sample preparation, a confirmatory method, or supplier clarification.
FAQ
Can a low whole-component XRF result release the part?
It may support a screening decision, but it does not automatically demonstrate that every homogeneous material is below its limit. Review the material map, measurement location, supplier evidence, and XRF capability before deciding whether separation or confirmation is required.
Does low total bromine prove that PBB and PBDE are absent?
A validated low screening result can support a low-risk classification. It is not compound-specific quantification. When confirmation is required, use a method suitable for PBB/PBDE in the relevant polymer and retain the method’s reporting limits.
Is “ND” the same as zero?
No. Not detected means the analyte was below the method’s detection or reporting limit under the stated conditions. The limit, sample mass, matrix, preparation, and units must still be low enough to support the regulatory decision.
Does a supplier RoHS declaration remove the need for testing?
There is no universal yes-or-no answer. Part-specific, current, controlled documentation may be strong evidence for a stable low-risk source. Higher-risk materials, changes, inconsistent documents, or near-threshold screens justify targeted verification.
Practical conclusion
RoHS compliance is not established by the existence of a whole-part test report. It is established by a traceable evidence chain that connects the purchased part to the correct homogeneous materials, restricted substances, analytical methods, limits, exemptions, and change controls. Map the materials first, use XRF for what it can screen, apply compound-specific confirmation where needed, and preserve uncertainty rather than averaging it away.
Continue with Electronic Component Abbreviations and BOM Terms, Electronic Component Types and Functions, MLV Reliability, Standards and Failure Modes, and the difference between component standards and approvals.
References
- Directive 2011/65/EU (RoHS)
- Commission Delegated Directive (EU) 2015/863
- European Commission, RoHS 2 FAQ guidance
- Commission Implementing Decision (EU) 2020/659 (EN IEC 63000:2018)
- IEC 62321-1:2013 — Introduction and overview
- IEC 62321-3-1:2026 — XRF screening
- IEC 62321-12:2023 — PBB, PBDE and phthalates by GC-MS












